IPP Bureau
Eli Lilly drug slashes lung cancer recurrence risk by 83% in landmark phase 3 trial
By IPP Bureau - June 02, 2026
The trial results are for the pharma powerhouse's RET-targeted therapy Retevmo (selpercatinib)
Ebola vax on the anvil?
By IPP Bureau - June 02, 2026
CEPI will commit up to US $50 million to fund preclinical research and Phase 1 clinical trials of Moderna’s mRNA-based vaccine candidate
Hyderabad gets new 'Oval' fertility hub
By IPP Bureau - June 02, 2026
Fertility platform launches flagship clinic with advanced IVF tech
Yoginii partners with Panacea Biotec to expand wellness portfolio
By IPP Bureau - June 02, 2026
Collaboration brings Staart Prime, ChilRun and NikoMom products to Yoginii’s platform, strengthening its family-focused wellness ecosystem and supporting women through motherhood and family care
M|O|C Cancer Care’s research gains global recognition at ASCO 2026
By IPP Bureau - June 02, 2026
The accepted studies span several critical areas of oncology, including nutrition, genomics, precision medicine, patient-reported outcomes, and community-based cancer care
Bristol Myers Squibb wins EU approval for Opdivo-based frontline treatment in advanced hodgkin lymphoma
By IPP Bureau - June 02, 2026
The approval is supported by results from the Phase 3 SWOG 1826 trial
STRIDE-based regimens show survival momentum in EMERALD-3 liver cancer trial
By IPP Bureau - June 02, 2026
While overall survival data remain immature, the results pointed to a favourable trend.
Aragen scales Renaissance Pharma’s cancer antibody to commercial GMP in just 9 months
By IPP Bureau - June 02, 2026
Anti-GD2 monoclonal antibody for high-risk neuroblastoma advances toward BLA submission following successful tech transfer from California to Bengaluru
Imaging Endpoints appoints Srikanth Ayyappan as AVP, Global Marketing
By IPP Bureau - June 02, 2026
Based in the global marketing function, he will be responsible for strengthening the company's visibility among sponsors, partners and industry stakeholders worldwide
AIIMS Delhi and Raipur use Intuitive’s tech to conduct tele-mentored robotic surgery
By IPP Bureau - June 02, 2026
Real-time remote collaboration during robotic-assisted cholecystectomy showcases new possibilities for surgical mentoring, education, and knowledge sharing across institutions
World No Tobacco Day: HCG Cancer Hospital Mumbai holds awareness campaigns
By IPP Bureau - June 01, 2026
Initiatives at Churchgate Station and Mahindra & Mahindra focus on early detection, public education, and tobacco-related cancer prevention
AstraZeneca's India revenue climbs 33% YoY to Rs. 22.76 billion in FY26
By IPP Bureau - June 01, 2026
While oncology contributed Rs. 16,100.9 million to remain company's largest therapy area, the key highlight was receipt of 11 new regulatory approvals for medicines and indications
proRITHM ranked among top healthcare innovations in Andhra Pradesh
By IPP Bureau - June 01, 2026
AI-enabled wearable remote patient monitoring platform successfully completed pilot deployments in a government super-specialty hospital and emergency ambulances
Takeda promotes Garima Srivastava as VP HR, Global Head of Talent Acquisition for Commercial
By IPP Bureau - June 01, 2026
Seasoned HR leader brings over 15 years of experience in global talent strategy, organizational transformation, and workforce planning
Sanofi brings AI-driven rare disease diagnostic tool AccelRare to India
By IPP Bureau - June 01, 2026
Approved as a web-based pre-diagnostic tool for suspected rare diseases and classified as a Class A (non-sterile and non-measuring) medical device
